Bulletin 2011/51 - European Patent Office
26.02.2013 • Views
Share Embed Flag

Bulletin 2011/51 - European Patent Office

Bulletin 2011/51 - European Patent Office

Bulletin 2011/51 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) I.1(1)<br />

• TREATING INFLAMMATION AND INFLAM-<br />

MATORY PAIN IN MUCOSA USING<br />

MUCOSAL PROLONGED RELEASE BIOAD-<br />

HESIVE THERAPEUTIC CARRIERS.<br />

• TRAITEMENT D'INFLAMMATIONS ET DE<br />

DOULEURS INFLAMMATOIRES DANS UNE<br />

MUQUEUSE À L'AIDE DE SUPPORTS<br />

THÉRAPEUTIQUES BIOADHÉSIFS À LIBÉ-<br />

RATION MUCOSALE PROLONGÉE<br />

(71) BioAlliance Pharma, 49, boulevard du Général<br />

Martial Valin, 75015 Paris, FR<br />

(72) ATTALI, Pierre, F-94300 Vincennes, FR<br />

LEMARCHAND, Caroline, F-75014 Paris, FR<br />

ROULET, Vanessa, F-75017 Paris, FR<br />

SCHEUIR, Claire, F-91160 Longjumeau, FR<br />

ZAKIN, Lorraine, F-92700 Colombes, FR<br />

(74) Vaillant, Jeanne, et al, Ernest Gutmann - Yves<br />

Plasseraud S.A.S. 3, rue Auber, 75009 Paris,<br />

FR<br />

A61K 31/415 → (<strong>51</strong>) A01N 43/50<br />

A61K 31/415 → (<strong>51</strong>) A61K 9/22<br />

(<strong>51</strong>) A61K 31/4164 (11) 2 395 998 A1*<br />

A61K 31/498 A61K 31/7048<br />

A61K 45/06<br />

(25) Fr (26) Fr<br />

(21) 10709876.6 (22) 16.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA RS<br />

(86) FR 2010/050259 16.02.2010<br />

(87) WO 2010/092312 2010/33 19.08.2010<br />

(30) 16.02.2009 FR 0950981<br />

(54) • KOMBINATION AUS AVERMECTINEN<br />

ODER MILBEMYCINEN MIT ADRENERGI-<br />

SCHEN REZEPTOREN ZUR BEHANDLUNG<br />

ODER PRÄVENTION VON HAUTKRANK-<br />

HEITEN<br />

• COMBINATION OF AVERMECTINS OR<br />

MYLBEMYCINS WITH ADRENERGIC<br />

RECEPTORS FOR TREATING OR PRE-<br />

VENTING SKIN DISEASES<br />

• ASSOCIATION D' AVERMECTINES OU<br />

MYLBEMYCINES AVEC DES RÉCEPTEURS<br />

ADRÉNERGIQUES POUR LE TRAITEMENT<br />

OU LA PRÉVENTION DES AFFECTIONS<br />

DERMATOLOGIQUES<br />

(71) Galderma Research & Development, 2400<br />

Route des Colles Les Templiers, 06410 Biot,<br />

FR<br />

(72) JOMARD, André, 06460 Saint Vallier De<br />

Thiey, FR<br />

FREDON, Laurent, 06330 Roquefort Les<br />

Pins, FR<br />

ROYE, Olivier, 83440 Fayence, FR<br />

(74) Allab, Myriam, L'Oréal D.I.P.I. 25-29 Quai<br />

Aulagnier, 92600 Asnières, FR<br />

A61K 31/4164 → (<strong>51</strong>) C07D 233/84<br />

(<strong>51</strong>) A61K 31/4174 (11) 2 395 999 A1*<br />

A61P 23/00<br />

(25) En (26) En<br />

(21) 10706824.9 (22) 12.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/024111 12.02.2010<br />

(87) WO 2010/093930 2010/33 19.08.2010<br />

(30) 13.02.2009 US 152494 P<br />

(54) • PHARMAZEUTISCHE ZUSAMMENSET-<br />

ZUNGEN MIT (3-(1-(1H-IMIDAZOL-4-YL)<br />

ETHYL)-2-METHYLPHENYL)METHANOL<br />

• PHARMACEUTICAL COMPOSITIONS<br />

COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)<br />

ETHYL)-2-METHYLPHENYL)METHANOL<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

• COMPOSITIONS PHARMACEUTIQUES<br />

COMPRENANT DU (3-(1-(1H-IMIDAZOL-4-<br />

YL)ÉTHYL)-2-MÉTHYLPHÉNYL)MÉTHA-<br />

NOL<br />

(71) Allergan, Inc., 2525 Dupont Drive, T2-7H,<br />

Irvine, CA 92612, US<br />

(72) GIL, Daniel W., Corona Del Mar California<br />

92625, US<br />

(74) HOFFMANN EITLE, <strong>Patent</strong>- und Rechtsanwälte<br />

Arabellastraße 4, 81925 München, DE<br />

A61K 31/4178 → (<strong>51</strong>) C07D 233/64<br />

(<strong>51</strong>) A61K 31/4188 (11) 2 396 000 A1*<br />

A61K 38/17 A61P 9/10<br />

(25) En (26) En<br />

(21) 10718352.7 (22) 11.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/023864 11.02.2010<br />

(87) WO 2010/093771 2010/33 19.08.2010<br />

(30) 11.02.2009 US 207376 P<br />

(54) • VEGFR2-KOMBINATIONSTHERAPIE MIT<br />

TEMOZOLOMID<br />

• COMBINATION VEGFR2 THERAPY WITH<br />

TEMOZOLOMIDE<br />

• THÉRAPIE VEGFR2 DE COMBINAISON<br />

AVEC LE TÉMOZOLOMIDE<br />

(71) Bristol-Myers Squibb Company, Route 206<br />

& Province Line Road, Princeton, NJ 08543-<br />

4000, US<br />

(72) CARVAJAL, Irvith, M., Brighton, MA 02135,<br />

US<br />

(74) Reitstötter - Kinzebach, <strong>Patent</strong>anwälte<br />

Sternwartstrasse 4, 81679 München, DE<br />

A61K 31/4192 → (<strong>51</strong>) A61K 31/216<br />

A61K 31/4196 → (<strong>51</strong>) C07D 233/64<br />

A61K 31/42 → (<strong>51</strong>) A61K 31/33<br />

A61K 31/4245 → (<strong>51</strong>) A61K 9/00<br />

A61K 31/431 → (<strong>51</strong>) A61K 9/00<br />

A61K 31/4355 → (<strong>51</strong>) C07D 471/04<br />

A61K 31/437 → (<strong>51</strong>) A61M 31/00<br />

A61K 31/437 → (<strong>51</strong>) C07D 471/04<br />

A61K 31/4375 → (<strong>51</strong>) C07D 471/04<br />

A61K 31/439 → (<strong>51</strong>) A61K 31/216<br />

A61K 31/44 → (<strong>51</strong>) A01N 43/40<br />

A61K 31/44 → (<strong>51</strong>) A61K 31/33<br />

A61K 31/4409 → (<strong>51</strong>) A61K 31/33<br />

A61K 31/4412 → (<strong>51</strong>) A61K 38/18<br />

A61K 31/4418 → (<strong>51</strong>) C07D 213/80<br />

A61K 31/4418 → (<strong>51</strong>) C07D 213/82<br />

(<strong>51</strong>) A61K 31/443 (11) 2 396 001 A1*<br />

A61K 9/20 A61P 9/10<br />

(25) En (26) En<br />

(21) 10703784.8 (22) 09.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/023628 09.02.2010<br />

(87) WO 2010/093629 2010/33 19.08.2010<br />

(30) 12.02.2009 US 152080 P<br />

39<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>51</strong>/<strong>2011</strong>) 21.12.<strong>2011</strong><br />

(54) • PAR-1-ANTAGONISMUS IN GEFÜTTERTEN<br />

ODER MIT ANTAZID BEHANDELTEN<br />

PATIENTEN<br />

• PAR-1 ANTAGONISM IN FED OR ANTA-<br />

CID-DOSED PATIENTS<br />

• ANTAGONISME PAR-1 CHEZ DES<br />

PATIENTS NOURRIS OU AYANT REÇU<br />

UNE DOSE D'ANTIACIDE<br />

(71) Schering Corporation, 2000 Galloping Hill<br />

Road, Kenilworth, NJ 07033, US<br />

(72) REYDERMAN, Larisa, Watchung New Jersey<br />

07069, US<br />

KOSOGLOU, Teddy, Jamison Pennsylvania<br />

18929, US<br />

(74) Hussain, Deeba, Merck Sharp & Dohme<br />

Limited Hertford Road, Hoddesdon Hertfordshire<br />

EN11 9BU, GB<br />

A61K 31/4439 → (<strong>51</strong>) A61K 31/00<br />

A61K 31/445 → (<strong>51</strong>) A01N 43/40<br />

A61K 31/445 → (<strong>51</strong>) A61K 9/22<br />

A61K 31/454 → (<strong>51</strong>) C07D 401/04<br />

(<strong>51</strong>) A61K 31/46 (11) 2 396 002 A2*<br />

A61P 25/08<br />

(25) En (26) En<br />

(21) 09833871.8 (22) 21.12.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA<br />

(86) US 2009/068920 21.12.2009<br />

(87) WO 2010/071872 2010/25 24.06.2010<br />

(88) 25.11.2010<br />

(30) 20.12.2008 US 139562 P<br />

(54) • (2.2.2) BICYCLISCHE DERIVATE UND<br />

ANWENDUNGSVERFAHREN<br />

• (2.2.2) BICYCLIC DERIVATIVES AND<br />

METHODS OF USE<br />

• DÉRIVÉS BICYCLIQUES (2.2.2) ET LEURS<br />

PROCÉDÉS D UTILISATION<br />

(71) Saakian, Susanna, A., 15 Smolensky Blvd.,<br />

Apt 68, Moscow 119121, RU<br />

(72) Saakian, Susanna, A., Moscow 119121, RU<br />

(74) Hart, Deborah Mary, et al, Kilburn & Strode<br />

LLP 20 Red Lion Street, London WC1R 4PJ,<br />

GB<br />

A61K 31/465 → (<strong>51</strong>) A61K 9/08<br />

A61K 31/4709 → (<strong>51</strong>) C07D 401/12<br />

A61K 31/473 → (<strong>51</strong>) A61K 9/107<br />

(<strong>51</strong>) A61K 31/4745 (11) 2 396 003 A2*<br />

A61K 45/06 A61P 35/00<br />

(25) En (26) En<br />

(21) 10704696.3 (22) 11.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/023893 11.02.2010<br />

(87) WO 2010/093789 2010/33 19.08.2010<br />

(88) 02.12.2010<br />

(30) 12.02.2009 US 152138 P<br />

17.04.2009 US 170471 P<br />

(54) • ZUSAMMENSETZUNG MIT (-)-TRANS-3-<br />

(5,6-DIHYDRO-4H-PYRROLO [3,2,1-IJ]<br />

CHINOLIN-1-YL)-4-(1H-INDOL-3-YL) PYR-<br />

ROLIDIN-2,5-DION KOMBINIERT MIT<br />

EINEM ZWEITEN ANTIPROLIFERATIONS-<br />

MITTEL

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!